Mediation Analysis of Inflammatory Biomarkers in the Association Between Metabolic Dysfunction–Associated Steatotic Liver Disease and Sarcopenia Among US Adults With Type 2 Diabetes or Prediabetes
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/3157645 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 15.11.2026. Verfasst von Lu Long und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine The Second Affiliated Hospital Jiangxi Medical College Nanchang University Nanchang Jiangxi China ncu.edu.cn. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Metabolic dysfunction–associated steatotic liver disease (MASLD) is strongly linked to metabolic disorders, including insulin resistance and obesity, yet its association with sarcopenia, particularly in individuals with type 2 diabetes (T2DM) or prediabetes, remains poorly characterized. This study examined the association between MASLD and sarcopenia in U.S. adults with T2DM or prediabetes and investigated the potential mediating role of inflammatory biomarkers.
Methods
Data were obtained from the National Health and Nutrition Examination Survey (NHANES) 1999–2006 and 2011–2018 cycles. Multivariable logistic regression and restricted cubic spline analyses were conducted to investigate the association between US FLI and sarcopenia, while mediation analysis was performed to explore the potential mediating role of inflammatory biomarkers in this association.
Results
Among the 2093 patients (weighted 9,501,956) with T2DM or prediabetes, 452 (17.10%) had sarcopenia. MASLD remained significantly associated with sarcopenia (OR = 2.12; 95% CI: 1.56–2.86) after fully adjusting for potential confounders. Restricted cubic spline analysis showed no evidence of a nonlinear association between US FLI and sarcopenia ( p for nonlinearity = 0.81). Mediation analyses yielded estimated mediation proportions of 10.35%, 9.14%, 8.98%, 6.47%, 4.28%, and 2.54% for the red cell distribution width‐to‐albumin ratio, white blood cell count, serum albumin, neutrophil percentage‐to‐albumin ratio, red blood cell distribution width, and systemic inflammation response index, respectively, in the association between MASLD and sarcopenia.
Conclusion
MASLD was significantly associated with sarcopenia among individuals with T2DM or prediabetes. Mediation analyses suggested a potential involvement of inflammatory biomarkers in this association.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine The Second Affiliated Hospital Jiangxi Medical College Nanchang University Nanchang Jiangxi China ncu.edu.cn.
- Department of Orthopedics The Second Affiliated Hospital Jiangxi Medical College Nanchang University Nanchang Jiangxi China ncu.edu.cn.
ORCID-Profile: Lu Long, Lei He, Juxiang Li
Zitieren
APA
Long, L., Shu, Z., Wang, W., He, L., Jiang, Y., Li, Q., Li, X., & Li, J. (2026). Mediation Analysis of Inflammatory Biomarkers in the Association Between Metabolic Dysfunction–Associated Steatotic Liver Disease and Sarcopenia Among US Adults With Type 2 Diabetes or Prediabetes. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/3157645
Vancouver
Long L, Shu Z, Wang W, He L, Jiang Y, Li Q, et al. Mediation Analysis of Inflammatory Biomarkers in the Association Between Metabolic Dysfunction–Associated Steatotic Liver Disease and Sarcopenia Among US Adults With Type 2 Diabetes or Prediabetes. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/3157645
BibTeX
@article{Long2026,
author = {Long, Lu and Shu, Zhiwen and Wang, Weixue and He, Lei and Jiang, Yuwen and Li, Qing and Li, Xiaozhong and Li, Juxiang},
title = {Mediation Analysis of Inflammatory Biomarkers in the Association Between Metabolic Dysfunction–Associated Steatotic Liver Disease and Sarcopenia Among US Adults With Type 2 Diabetes or Prediabetes},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/3157645}
}
EUVIMED